Oncology Podcasts & Vodcasts

Articles (27 in this collection)

1. Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors

   Authors

   • Eric Lowe
   • Yael P. Mossé

   • Content type: Commentary
   • Open Access
   • Published: 27 April 2024

   • Oncology and Therapy

2. Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example

   Authors

   • Ronan Foley
   • John Kuruvilla

   • Content type: Commentary
   • Open Access
   • Published: 25 April 2024

   • Oncology and Therapy

3. Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast

   Authors

   • Luciano J. Costa
   • Paula Rodriguez-Otero

   • Content type: Commentary
   • Open Access
   • Published: 20 April 2024

   • Advances in Therapy

4. The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast

   Authors

   • Fred R. Hirsch
   • Chul Kim

   • Content type: Commentary
   • Open Access
   • Published: 27 March 2024

   • Oncology and Therapy

5. Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example

   Authors

   • Kai Hübel

   • Content type: Commentary
   • Open Access
   • Published: 21 March 2024

   • Oncology and Therapy

6. A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives

   Authors (first, second and last of 4)

   • Luca Bertolaccini
   • Andrea De Giglio
   • Giulio Metro

   • Content type: Commentary
   • Open Access
   • Published: 14 March 2024

   • Oncology and Therapy

   

7. Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia—A Podcast

   Authors

   • Elias J. Jabbour
   • Matthias Stelljes

   • Content type: Commentary
   • Open Access
   • Published: 08 March 2024

   • Targeted Oncology
   • Pages: 135 - 141

8. The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast

   Authors

   • Peter C. Black
   • Bernhard J. Eigl

   • Content type: Commentary
   • Open Access
   • Published: 02 February 2024

   • Advances in Therapy
   • Pages: 915 - 927

   

9. Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion

   Authors

   • Sandip Patel
   • Jyoti D. Patel

   • Content type: Commentary
   • Open Access
   • Published: 06 October 2023

   • Advances in Therapy
   • Pages: 5579 - 5590

10. EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

    Authors (first, second and last of 4)

    • Xiuning Le
    • Eric Nadler
    • John Victor Heymach

    • Content type: Commentary
    • Open Access
    • Published: 04 October 2023

    • Targeted Oncology
    • Pages: 807 - 817

    

11. Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast

    Authors

    • Wade T. Iams
    • Kartik Konduri

    • Content type: Commentary
    • Open Access
    • Published: 01 October 2023

    • Advances in Therapy
    • Pages: 5567 - 5578

12. Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast

    Authors (first, second and last of 4)

    • Brian Dong
    • Rita Lusen
    • Lisa Kline

    • Content type: Commentary
    • Open Access
    • Published: 29 September 2023

    • Oncology and Therapy
    • Pages: 411 - 418

    

13. EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists

    Authors (first, second and last of 4)

    • Stephen V. Liu
    • Ivy B. Elkins
    • Sarah B. Goldberg

    • Content type: Commentary
    • Open Access
    • Published: 26 September 2023

    • Oncology and Therapy
    • Pages: 419 - 431

14. Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast

    Authors

    • Reva Basho
    • Megan-Claire Chase

    • Content type: Commentary
    • Open Access
    • Published: 14 September 2023

    • Oncology and Therapy
    • Pages: 433 - 443

    

15. Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis

    Authors

    • Geoffrey Liu
    • Vincent K. Lam

    • Content type: Commentary
    • Open Access
    • Published: 12 August 2023

    • Advances in Therapy
    • Pages: 4117 - 4126

16. A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma

    Authors (first, second and last of 4)

    • Philipp Ivanyi
    • Jonas Paul Wiegmann
    • Viktor Grünwald

    • Content type: Commentary
    • Open Access
    • Published: 12 July 2023

    • Advances in Therapy
    • Pages: 3610 - 3619

17. First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely

    Authors (first, second and last of 4)

    • Philipp Ivanyi
    • Jonas Paul Wiegmann
    • Viktor Grünwald

    • Content type: Commentary
    • Open Access
    • Published: 12 July 2023

    • Advances in Therapy
    • Pages: 3620 - 3625

18. Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast

    Authors

    • Ola Landgren
    • Omar Nadeem

    • Content type: Commentary
    • Open Access
    • Published: 16 June 2023

    • Advances in Therapy
    • Pages: 3291 - 3303

19. Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast

    Authors

    • Alex Filicevas
    • Thomas Powles

    • Content type: Commentary
    • Open Access
    • Published: 06 June 2023

    • Oncology and Therapy
    • Pages: 277 - 289

20. Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

    Authors

    • Moshe C. Ornstein
    • Laura S. Wood

    • Content type: Commentary
    • Open Access
    • Published: 26 May 2023

    • Advances in Therapy
    • Pages: 3599 - 3609

    

21. P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer—A Podcast

    Authors

    • Adam Brufsky
    • Christopher Gallagher

    • Content type: Commentary
    • Open Access
    • Published: 06 May 2023

    • Targeted Oncology
    • Pages: 321 - 326

    

22. HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast

    Authors

    • Aditya Bardia
    • Giuseppe Viale

    • Content type: Commentary
    • Open Access
    • Published: 03 May 2023

    • Targeted Oncology
    • Pages: 313 - 319

23. Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer: A Podcast

    Authors (first, second and last of 4)

    • Thomas John
    • Margarita Majem
    • Jonathan Goldman

    • Content type: Commentary
    • Open Access
    • Published: 19 December 2022

    • Targeted Oncology
    • Pages: 1 - 8

24. Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast

    Authors

    • Alex Filicevas
    • Thomas B. Powles

    • Content type: Commentary
    • Open Access
    • Published: 03 March 2022

    • Oncology and Therapy
    • Pages: 1 - 11

25. Podcast on the Management of Adverse Events Associated with Lorlatinib

    Authors

    • Todd M. Bauer
    • Erin M. Bertino

    • Content type: Commentary
    • Open Access
    • Published: 11 February 2022

    • Advances in Therapy
    • Pages: 1447 - 1456

26. Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments

    Authors

    • Massimo Breccia

    • Content type: Commentary
    • Open Access
    • Published: 31 January 2022

    • Advances in Therapy
    • Pages: 1101 - 1106

27. American Society of Clinical Oncology 2021 Podcast: HR+, HER2− Breast Cancer

    Authors

    • Kwok-Leung Cheung

    • Content type: Commentary
    • Open Access
    • Published: 07 August 2021

    • Oncology and Therapy
    • Pages: 267 - 272